Skip to main content

Table 2 Hypertonic saline after a damage control laparotomy. Randomized controlled clinical trial. Outcomes

From: Hypertonic saline infusion does not improve the chance of primary fascial closure after damage control laparotomy: a randomized controlled trial

Outcome

NS

HS

p

Abdominal closure in the first 7 days, n (%)

17/24 (70.8%)

19/24 (79.2%)

0.711

Day 28 mortality, n (%)

3/26 (11.5%)

2/24 (8.0%)

1.002

Abdominal compartment syndrome, n (%)

0 (–)

2 (8.0%)

0.272

Total SOFA score

5 (7.5–9)

6 (4–14)

0.953

Number of subjects with SOFA score > 6, n (%)

13 (59.1%)

12 (48.0%)

0.321

ICU-free days in the first 30 days, median (IQR)

16 (1–23)

19 (11–24)

0.573

Fluid balance

   

 Day 1, c.c., median (IQR)

2165 (1180–4119)

1828 (427–3344)

0.213

 Day 2, c.c., median (IQR)

678 (106–1599)

387 (− 125–1165)

0.583

 Day 3, c.c., median (IQR)

261 (− 32–950)

170 (− 136–580)

0.433

 First 72 h, c.c., median (IQR)

3957 (1767–5946)

2486 (650–5578)

0.293

  1. NS normal saline HS hypertonic saline IQR interquartile range
  2. 1Chi2
  3. 2Fisher’s Exact test
  4. 3Wilcoxon–Mann–Whitney